S'abonner

Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study - 27/05/21

Doi : 10.1016/S1473-3099(20)30596-X 
Houyu Zhao, PhD a, Li Wei, PhD c, Hui Li, MD d, Mei Zhang, ProfMS e, Bin Cao, ProfMD d, Jiaming Bian, PhD e, , , Siyan Zhan, ProfPhD a, b, f, ,
a Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China 
b Center for Intelligent Public Health, Institute for Artificial Intelligence, Peking University, Beijing, China 
c Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK 
d Department of Pulmonary and Critical Care Medicine, Center for Respiratory Diseases, China–Japan Friendship Hospital, Beijing, China 
e Department of Pharmacology, 7th Medical Center of Chinese PLA General Hospital, Beijing, China 
f Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China 

* Correspondence to: Prof Siyan Zhan, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Department of Epidemiology and Biostatistics School of Public Health Peking University Beijing 100191 China ** Dr Jiaming Bian, Department of Pharmacology, 7th Medical Center of Chinese PLA General Hospital, Beijing 100700, China Department of Pharmacology 7th Medical Center of Chinese PLA General Hospital Beijing 100700 China

Summary

Background

Inappropriate antibiotic use greatly accelerates antimicrobial resistance. The appropriateness of antibiotic prescriptions is well evaluated, using big observational data, in some high-income countries, whereas the evidence of this appropriateness is scarce in China. We aimed to assess the appropriateness of antibiotic prescriptions in ambulatory care settings in China to inform future antimicrobial stewardship.

Methods

We used data from the Beijing Data Center for Rational Use of Drugs, which was a national database designed for monitoring rationality of drug use. 139 hospitals that uploaded diagnosis and prescription information were included from 28 provincial-level regions of mainland China. Outpatient prescriptions were classified as appropriate, potentially appropriate, inappropriate, or not linked to any diagnosis for antibiotic use by following a published classification scheme. Antibiotic prescription rates for various diagnosis categories and proportions of inappropriate antibiotic prescriptions for different subgroups were estimated. Antibiotic prescribing patterns and proportions of individual antibiotics prescribed for different diagnosis categories were analysed and reported.

Findings

Between Oct 1, 2014, and April 30, 2018, 18 848 864 (10·9%) of 172 704 117 outpatient visits ended with antibiotic prescriptions. For conditions for which antibiotic use was appropriate, potentially appropriate, and inappropriate, 42·2%, 30·6%, and 7·6% of visits were associated with antibiotic prescriptions, respectively. Of all 18 848 864 antibiotic prescriptions, 9 689 937 (51·4%) were inappropriate, 5 354 224 (28·4%) were potentially appropriate, 2 893 102 (15·3%) were appropriate, and 911 601 (4·8%) could not be linked to any diagnosis. A total of 23 266 494 individual antibiotics were prescribed, of which 18 620 086 (80·0%) were broad-spectrum and the top four most prescribed antibiotics were third-generation cephalosporins (5 056 058 [21·7%]), second-generation cephalosporins (3 823 410 [16·4%]), macrolides (3 554 348 [15·3%]), and fluoroquinolones (3 285 765 [14·1%]).

Interpretation

Inappropriate antibiotic prescribing was highly prevalent nationwide in China. Over half of the antibiotic prescriptions were inappropriate in secondary-level and tertiary-level hospitals, suggesting an urgent need for outpatient antibiotic stewardship aimed at optimising antibiotic prescribing to achieve the goals set in China’s 2016 national action plan to contain antimicrobial resistance.

Funding

The National Natural Science Foundation of China.

Le texte complet de cet article est disponible en PDF.

Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 21 - N° 6

P. 847-857 - juin 2021 Retour au numéro
Article précédent Article précédent
  • Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
  • Ed Clarke, Adedapo Bashorun, Ikechukwu Adigweme, Mariama Badjie Hydara, Ama Umesi, Ahmed Futa, Magnus Ochoge, Dolapo Obayemi, Bassey Edem, Ebrima Saidy-Jah, Chukwuemeka Onwuchekwa, Rajeev Dhere, Vistasp Sethna, Beate Kampmann, David Goldblatt, Douglas Taylor, Indah Andi-Lolo, Nancy Hosken, Kalpana Antony, Bruce L Innis, Mark R Alderson, Steve Lamola
| Article suivant Article suivant
  • Routine universal testing versus selective or incidental testing for oropharyngeal Neisseria gonorrhoeae in women in the Netherlands: a retrospective cohort study
  • Geneviève A F S van Liere, Nicole H T M Dukers-Muijrers, Sophie Kuizenga-Wessel, Petra F G Wolffs, Christian J P A Hoebe

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.